Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-02-28 @ 2:11 PM
Study NCT ID:
NCT02503332
Status:
COMPLETED
Last Update Posted:
2020-10-06
First Post:
2015-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
Sponsor:
Apellis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-14
First Submit QC Date:
None
Study First Post Date:
2015-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-08-04
Results First Submit QC Date:
None
Results First Post Date:
2020-10-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-11-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-09-14
Last Update Post Date:
2020-10-06
Last Update Post Date Type:
ACTUAL